Treat Hypertension, Nix Kidney Failure

By Ezzell, Carol | Science News, December 5, 1992 | Go to article overview

Treat Hypertension, Nix Kidney Failure


Ezzell, Carol, Science News


Treating elevated blood pressure can halt -- and even repair - kidney damage caused by the disorder, according to a new analysis of a large study. However, the renal benefits of lowering blood pressure extend only to nonblacks: For as-yet-unknown reasons, blacks with hypertension tend to go on to develop kidney damage whether they receive treatment for the disorder or not, the study found.

The results represent the first time researchers have proved that mild hypertension -- defined as blood pressure between 140/90 millimeters of mercury (mm Hg) and 159/99 mm Hg -- or moderate hypertension -- between 160/100 mm Hg and 179/109 mm Hg -- in fact impairs kidney function. Previous studies only suggested a link between kidney damage and blood pressures in either of these two ranges, which physicians now refer to as stage 1 and stage 2 hypertension, respectively (SN: 11/7/92, p.311).

Kidney dialysis centers estimate that the renal failure of roughly one-third of all new dialysis patients derives from damage caused by hypertension. Besides serverely curtailing patients' lives, these new dialysis cases add approximately $300 million per year to already spiraling U.S. health care costs, according to the National Institute of Diabetes and Digestive and Kidney Diseases in Bethesda, Md.

To confirm the hypertension-kidney damage connection, a research team led by W. Gordon Walker of Johns Hopkins University School of Medicine in Baltimore measured concentrations of a waste protein called creatinine in the blood of 5.524 hypertensive men of all races. Because the kidneys usually filter creatinine -- a by-product of normal metabolism -- out of the blood and into the urine, blood creatinine measurements can indicate whether a patient's kidneys are working properly.

The men studied by Walker's group were a subset of participants in the Multiple Risk Factor Intervention Trial (MRFIT), an even larger study evaluating measures to prevent heart disease among men at risk for the disorder because of cigarette smoking, elevated blood cholesterol, or elevated blood pressure. As part of the MRFIT design, roughly half of the men were given a standardized regimen of drug therapy and put on a modified diet to control their blood pressure. The other half received a variety of different drugs and diet advice from their own physicians.

Walker's group found that the same treatments effectively controlled blood pressure among both blacks and non-blacks, most of whom were white. …

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • A full archive of books and articles related to this one
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Treat Hypertension, Nix Kidney Failure
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Help
Full screen

matching results for page

    Questia reader help

    How to highlight and cite specific passages

    1. Click or tap the first word you want to select.
    2. Click or tap the last word you want to select, and you’ll see everything in between get selected.
    3. You’ll then get a menu of options like creating a highlight or a citation from that passage of text.

    OK, got it!

    Cited passage

    Style
    Citations are available only to our active members.
    Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

    1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

    Cited passage

    Thanks for trying Questia!

    Please continue trying out our research tools, but please note, full functionality is available only to our active members.

    Your work will be lost once you leave this Web page.

    For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

    Already a member? Log in now.